The global biomaterials market size is expected to reach USD 145.1 Billion in 2021 and register a revenue CAGR of 14.8%, according to the latest report by Reports and Data. Market revenue growth can be attributed to increasing number of accidents, rising prevalence of chronic diseases, and developments in biomaterials technologies.
Biomaterials are artificial or natural materials used to help in the healing process of injured tissues, muscles, bones, and organs function efficiently. These materials are being used to interact with biological systems that are designed to treat cardiovascular, orthopedic, neurological, and dental disorders. The global biomaterials market is expected to be driven by continuous technological developments and innovations in the biomaterials industry, increasing use of implantable devices, and high demand for plastic operations employing biomaterials among patients and healthcare professionals.
Biomaterials Market Overview:
The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.
Further key findings from the report suggest:
- Based on application (material type), the cardiovascular segment accounted for largest revenue share in 2021 and is expected to continue to contribute major revenue share over the forecast period. Natural biomaterials in cardiovascular biomaterials are expected to gain substantially high demand in the years to come, owing to various benefits offered by the product as compared to synthetic biomaterials in biocompatibility, biodegradability, and remodeling.
- Based on application, tissue engineering segment is expected to register robust revenue CAGR. Revenue growth of this segment can be attributed to rising prevalence of diabetes and obesity as a result of lifestyle changes across the globe.
- Based on end user, the hospitals clinics segment is expected to account for major revenue share over the forecast period, as a consequence of increased hospital admissions due to rising incidence of various chronic diseases and availability of competent personnel in hospitals and clinics.
- North America market accounted for largest revenue share in 2021, due to increasing initiatives by government and private organizations, high investments by major players in research developments and manufacturing of various products that require biomaterials are some of the key factors driving revenue growth of the market in this region.
- Asia Pacific is expected to register fastest revenue growth rate owing to increasing geriatric population along with rising patient pool in healthcare facilities due to increasing prevalence of various chronic diseases such as cardiovascular diseases and orthopedic replacement. For instance, cardiovascular diseases are one of the leading causes of mortality in countries in the region. In addition, strong presence of major players and strategic initiatives by government of countries in the region are factors supporting revenue growth of the Asia Pacific market.
- In November 2020, clean manufacturing leader Genomatica signed a first-of-its-kind deal with Aquafil to build a demonstration scale facility to produce the largest quantity of 100% renewable nylon-6 ever available. The deal has major impact on the sustainability of consumer products and biomaterials manufacturing technology to create a new demonstration facility.
Top Companies Profiled in the Report Include:
Berkeley Advanced Biomaterials, Royal DSM, Carpenter Technology Corporation, BASF SE, Corbion, Cam Bioceramics B.V., Celanese Corporation, CoorsTek Inc., CeramTec, Evonik Industries, and GELITA AG.
Additionally, the report consists a detailed analysis of the segmentation of the PTA Balloon Cathetery tests Market based on product types and end-use/application offered in the PTA Balloon Cathetery tests Market –
Application (Material Type) Outlook (Revenue, USD Billion, 2019 - 2030)
- Cardiovascular
- Natural Biomaterials
- Small intestine submucosa
- Pericardium
- Engineered tissues
- Other
- Synthetic biomaterials
- Polymers
- Polyurethane
- Other
- Metals
- Titanium
- Stainless steel
- Alloy
- Composite biomaterials
- Orthopedic
- Metals
- Stainless steel
- Alloy
- Titanium
- Polymers
- Polymethacrylate
- Polyethylene
- Polypropylene (PP)
- Other
- Ceramic
- Calcium phosphate
- Glass
- Aluminum Oxide
- Other
- Ophthalmology
- Silicone
- Polymethacrylate
- Cellulose acetate butyrate
- Other
- Dental
- Metals
- Stainless steel
- Alloy
- Titanium
- Polymers
- Polyurethane
- Polyamide
- Polyurethane
- Zirconia
- Other
- Ceramic
- Carbon
- Glass
- Aluminum Oxide
- Other
- Plastic Surgery
- Natural Biomaterials
- Collagen
- Hyaluronic acid
- Other
- Synthetic Biomaterials
- Polymers
- Polymethyl methacrylate (PMMA)
- Silicone
- Other
- Ceramic Materials
- Hydroxyapatite
- Glass
- Other
- Wound Healing
- Natural Biomaterials
- Chitosan
- Cellulose
- Other
- Synthetic Biomaterials
- Polyethylene
- Polyurethane
- Polycaprolactone
- Other
- Tissue Engineering
- Ceramics
- Glass
- Hydroxyapatite
- Other
- Metals
- Alloy
- Titanium
- Other
- Polymers
- Polymethyl methacrylate (PMMA)
- Poly(lactide-co-glycolide)
- Other
- Other
- Neurological/Central Nervous System Applications
- Synthetic Biomaterials
- Silicone
- Polyglycolic acid (PGA)
- Other
- Natural Biomaterials
- Collagen
- Chitosan
- Hyaluronic acid
- Other
- Other Applications
- Natural Biomaterials
- Synthetic biomaterials
- Other biomaterials
Application Outlook (Revenue, USD Billion, 2019 - 2030)
- Cardiovascular
- Catheters
- Stents
- Implantable Cardiac Defibrillators
- Pacemakers
- Sensors
- Heart Valves
- Vascular Grafts
- Guidewires
- Others
- Orthopedic
- Joint Replacement
- Knee Replacement
- Hip Replacement
- Shoulder Replacement
- Others
- Viscosupplementation
- Bioresorbable Tissue Fixation
- Suture Anchors
- Interference Screws
- Meniscal Repair Tacks
- Meshes
- Spine
- Spinal Fusion Surgeries
- Minimally Invasive Fusion Surgeries
- Motion Preservation Dynamic Stabilization Surgeries
- Pedicle-Based Rod Systems
- Interspinous Spacers
- Artificial Discs
- Fracture Fixation Devices
- Bone Plates
- Screws
- Pins
- Rods
- Wires
- Synthetics Bone Grafts
- Ophthalmology
- Intraocular Lenses
- Functional Replacement of Ocular Tissues
- Synthetic Corneas
- Others
- Dental
- Dental Implants
- Dental Bone Grafts Substitutes
- Dental Membranes
- Tissue Regeneration
- Plastic Surgery
- Soft-Tissue Fillers
- Craniofacial Surgery
- Wound Healing
- Wound Closure Devices
- Sutures
- Staples
- Surgical Hemostats
- Internal Tissue Sealants
- Adhesion Barriers
- Hernia Meshes
- Tissue Engineering
- Scaffolds for Regenerative Medicine
- Nanomaterials for Biosensing
- Tailoring of Inorganic Nanoparticles
- Neurological/Central Nervous System Applications
- Shunting Systems
- Cortical Neural Prosthetics
- Hydrogel Scaffolds for CNS Repair
- Neural Stem Cell Encapsulation
- Other Applications
- Drug Delivery Systems
- Gastrointestinal Applications
- Bariatric Surgery
- Urinary Applications
End Use Outlook (Revenue, USD Billion, 2019 - 2030)
- Hospitals Clinics
- Ambulatory Surgical Centers
- Other End Users
Key Regional Markets Studied in the Report:
- North America (U.S., Canada)
- Europe (U.K., Italy, Germany, France, Rest of EU)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- The Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Request for Customization this report - https://www.reportsanddata.com/request-customization-form/3003
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
